10.30.14
River Edge, N.J.-based Nephros Inc., which makes high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, has received 510(k) clearance from the U.S. Food and Drug Administration to market its DSU-H and SSU-H Ultrafilters for use in the hospital setting.
The DSU-H and SSU-H Ultrafilters are intended to be used to filter Environmental Protection Agency-quality drinking water. The filters retain bacteria, viruses and endotoxins, providing water suitable for patient washing and drinking. This is meant to aid in infection control. The filters also produce water that is suitable for wound cleansing, cleaning of equipment used in medical procedures and washing of surgeon's hands.
"The 510(k) clearance of our DSU-H and SSU-H Ultrafilters represents a significant step forward in helping hospitals and other healthcare facilities with their infection control strategies," said John C. Houghton, president and CEO of Nephros. "Nephros will be launching the DSU-H and SSU-H Ultrafilters in collaboration with its hospital distributors over the coming weeks."
The DSU-H and SSU-H Ultrafilters are intended to be used to filter Environmental Protection Agency-quality drinking water. The filters retain bacteria, viruses and endotoxins, providing water suitable for patient washing and drinking. This is meant to aid in infection control. The filters also produce water that is suitable for wound cleansing, cleaning of equipment used in medical procedures and washing of surgeon's hands.
"The 510(k) clearance of our DSU-H and SSU-H Ultrafilters represents a significant step forward in helping hospitals and other healthcare facilities with their infection control strategies," said John C. Houghton, president and CEO of Nephros. "Nephros will be launching the DSU-H and SSU-H Ultrafilters in collaboration with its hospital distributors over the coming weeks."